👉 The Cardiff Fluid is an innovative, non-invasive diagnostic tool developed by researchers at Cardiff University. It's a proprietary, cell-free DNA (cfDNA) liquid biopsy that analyzes circulating tumor DNA (ctDNA) in blood samples to detect various types of cancer, including colorectal, lung, and ovarian cancers. By isolating and sequencing ctDNA fragments, the test can identify specific genetic mutations associated with these cancers, enabling early detection, monitoring treatment efficacy, and potentially guiding personalized therapy. Unlike traditional tissue biopsies, the Cardiff Fluid is minimally invasive, requiring only a simple blood draw, making it more accessible and less burdensome for patients.
